R&D/Product
pipeline
Please move the screen left or right.
| Project | Target Disease | Domestic | Global | |||||
|---|---|---|---|---|---|---|---|---|
| Research | Pre-clinical | Pivotal study | Approval | Pilot study | Pivotal study | Approval | ||
| CPB1401 | Urologicals | ‘20 2Q | ‘23 2Q | |||||
| CPB2101 | Non-narcotic analgesics | |||||||
| CPB2205 | NSAIDs | |||||||
| CPB2208 | Anti-virus | |||||||
| CPB1802 | CNS | ‘24 1Q | ‘24 1Q | |||||
| CPB1506 | Anti-virus | ’24 1Q | ||||||
| CPB2102 | Cardiovascular system | |||||||
| CPB2203 | Gastrointestinal | |||||||
| CPB2206 | Respiratory system | |||||||
| CPB2104 | Cardiovascular system | |||||||
